Washington State Life Science Investment Report – April 2025

• Policy Blog
• 2026

Policy Blog – March 9, 2026 – SBIR Reauthorization Clears US Senate, Legislature Enters Final Week of Session

The US Senate last week unanimously passed legislation to reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which provide critical early-stage funding for small Washington companies developing new technologies and therapies. The programs expired in October, but Congress is now moving to restore it. The House is also expected […]

• Policy Blog
• 2026

Policy Blog – March 2, 2026 – Final Weeks of Session: Budget Decisions, Taxes, and 340B in Focus

We are now in the two-week home stretch of the 2026 legislative session. All regular committee deadlines have passed, meaning most policy bills that have not already advanced are effectively done for the year, except for measures that impact state revenue or are deemed necessary to implement the budget (NTIB). With House and Senate budget […]

• Industry Reports
• 2026

Washington State Life Science Investment Report – January 2026

• Policy Blog
• 2026

Policy Blog – February 23, 2026 – Legislative Session Check-in: Where Things Stand with Three Weeks To Go

Join us for a virtual briefing on Thursday, February 26, 2026 at 1:00 PM PST for an update on this year’s state legislative session. LSW President & CEO Marc Cummings will also share insights from his recent meetings in Washington, DC, where he met with our Congressional delegation to discuss key federal issues. Contact Curtis Knapp, LSW’s […]